Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
出版年份 2021 全文链接
标题
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
作者
关键词
Shigella, Shigella flexneri 2a, Vaccine, Bioconjugate vaccine, Controlled human challenge study
出版物
EBioMedicine
Volume 66, Issue -, Pages 103310
出版商
Elsevier BV
发表日期
2021-04-15
DOI
10.1016/j.ebiom.2021.103310
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis
- (2019) John D Anderson et al. Lancet Global Health
- Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays
- (2019) Robert W Kaminski et al. CLINICAL INFECTIOUS DISEASES
- Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies
- (2019) Kawsar R Talaat et al. CLINICAL INFECTIOUS DISEASES
- Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints
- (2019) Calman A MacLennan et al. CLINICAL INFECTIOUS DISEASES
- Antibiotic-Resistant Enteric Infections
- (2019) Sadia Shakoor et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Shigellosis
- (2018) Karen L Kotloff et al. LANCET
- Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score
- (2018) Chad K. Porter et al. PLoS One
- Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants
- (2018) Megumi Inoue et al. Human Vaccines & Immunotherapeutics
- Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study
- (2018) Elizabeth T Rogawski et al. Lancet Global Health
- Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
- (2017) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
- (2016) Mark S. Riddle et al. Clinical and Vaccine Immunology
- Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial
- (2016) Ligia A. Pinto et al. JOURNAL OF INFECTIOUS DISEASES
- Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study
- (2016) Jie Liu et al. LANCET
- Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study
- (2015) Christoph F.R Hatz et al. VACCINE
- Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)
- (2015) James A Platts-Mills et al. Lancet Global Health
- Effects of Shigella-, Campylobacter- and ETEC-associated Diarrhea on Childhood Growth
- (2014) Gwenyth Lee et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The Shigella human challenge model
- (2012) C. K. PORTER et al. EPIDEMIOLOGY AND INFECTION
- Salivary Immune Responses to the 7-Valent Pneumococcal Conjugate Vaccine in the First 2 Years of Life
- (2012) Gerwin D. Rodenburg et al. PLoS One
- Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children
- (2010) Justen H. Passwell et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started